cbdMD Statistics
Total Valuation
cbdMD has a market cap or net worth of $6.42 million. The enterprise value is $6.32 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
cbdMD has 8.91 million shares outstanding. The number of shares has increased by 510.60% in one year.
Current Share Class | 8.91M |
Shares Outstanding | 8.91M |
Shares Change (YoY) | +510.60% |
Shares Change (QoQ) | +642.97% |
Owned by Insiders (%) | 1.74% |
Owned by Institutions (%) | 7.27% |
Float | 8.76M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.08 |
Forward PS | 0.32 |
PB Ratio | 1.05 |
P/TBV Ratio | 1.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.33 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.16.
Current Ratio | 1.56 |
Quick Ratio | 0.57 |
Debt / Equity | 0.16 |
Debt / EBITDA | 0.51 |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.13% and return on invested capital (ROIC) is -15.78%.
Return on Equity (ROE) | -33.13% |
Return on Assets (ROA) | -9.44% |
Return on Invested Capital (ROIC) | -15.78% |
Return on Capital Employed (ROCE) | -28.41% |
Revenue Per Employee | $453,002 |
Profits Per Employee | -$115,494 |
Employee Count | 42 |
Asset Turnover | 1.60 |
Inventory Turnover | 2.28 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.29% in the last 52 weeks. The beta is 2.30, so cbdMD's price volatility has been higher than the market average.
Beta (5Y) | 2.30 |
52-Week Price Change | -84.29% |
50-Day Moving Average | 0.85 |
200-Day Moving Average | 2.21 |
Relative Strength Index (RSI) | 43.03 |
Average Volume (20 Days) | 148,132 |
Short Selling Information
The latest short interest is 67,802, so 0.76% of the outstanding shares have been sold short.
Short Interest | 67,802 |
Short Previous Month | 41,796 |
Short % of Shares Out | 0.76% |
Short % of Float | 0.77% |
Short Ratio (days to cover) | 0.74 |
Income Statement
In the last 12 months, cbdMD had revenue of $19.03 million and -$4.85 million in losses. Loss per share was -$2.41.
Revenue | 19.03M |
Gross Profit | 11.64M |
Operating Income | -1.79M |
Pretax Income | -158,723 |
Net Income | -4.85M |
EBITDA | -641,470 |
EBIT | -1.79M |
Loss Per Share | -$2.41 |
Full Income Statement Balance Sheet
The company has $1.06 million in cash and $962,738 in debt, giving a net cash position of $96,821 or $0.01 per share.
Cash & Cash Equivalents | 1.06M |
Total Debt | 962,738 |
Net Cash | 96,821 |
Net Cash Per Share | $0.01 |
Equity (Book Value) | 6.11M |
Book Value Per Share | 0.69 |
Working Capital | 2.01M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$1.04 million and capital expenditures -$191,368, giving a free cash flow of -$1.24 million.
Operating Cash Flow | -1.04M |
Capital Expenditures | -191,368 |
Free Cash Flow | -1.24M |
FCF Per Share | -$0.14 |
Full Cash Flow Statement Margins
Gross margin is 61.20%, with operating and profit margins of -9.43% and -7.96%.
Gross Margin | 61.20% |
Operating Margin | -9.43% |
Pretax Margin | -7.96% |
Profit Margin | -7.96% |
EBITDA Margin | -3.37% |
EBIT Margin | -9.43% |
FCF Margin | n/a |
Dividends & Yields
cbdMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -510.60% |
Shareholder Yield | -510.60% |
Earnings Yield | -75.58% |
FCF Yield | -19.25% |
Analyst Forecast
The average price target for cbdMD is $2.00, which is 177.74% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $2.00 |
Price Target Difference | 177.74% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 7, 2025. It was a reverse split with a ratio of 1:8.
Last Split Date | May 7, 2025 |
Split Type | Reverse |
Split Ratio | 1:8 |
Scores
cbdMD has an Altman Z-Score of -23.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -23.29 |
Piotroski F-Score | 3 |